Health Sciences Authority approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years,
The Health Sciences Authority approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years, with vaccine rollout for this age group to begin before the end of the year.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthHealth Sciences Authority approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years,
View Premium plansBrowse free archive reportsThe Health Sciences Authority approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years, with vaccine rollout for this age group to begin before the end of the year.